跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Waisence Q23 Qing Re Capsule - NPRA Drug Approval Details
Approvals
/
NPRA
/
Waisence Q23 Qing Re Capsule
Approved
STANDARD
Waisence Q23 Qing Re Capsule
WAISENCE SDN BHD
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Aug 6, 2026
Approval ID
b3f024ab3af0e725
Company
WAISENCE SDN BHD
Type
Standard
Approval Details
Approval Id
b3f024ab3af0e725
Drug Approval Npra Name
Waisence Q23 Qing Re Capsule
Product Name
Waisence Q23 Qing Re Capsule
Registration Number
MAL26076060TC
Holder Company Name
WAISENCE SDN BHD
Holder Address
NO. 538, JALAN RIANG 11 HAPPY GARDEN OFF JALAN KUCHAI LAMA 58200 KUALA LUMPUR MALAYSIA
Holder Phone
0362768897
Manufacturer Company Name
WAN YEEN TRADING SDN. BHD.
Manufacturer Address
NO. 24, PERSIARAN INDUSTRI BERCHAM 11 KAWASAN PERINDUSTRIAN RINGAN BERCHAM 31400 IPOH MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL26076060TC
Version
1786043432
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Aug 6, 2026
Approval ID
b3f024ab3af0e725
Type
Standard
Source
Official Source
Back to NPRA Approvals